Supporting this hypothesis, our analysis of FGF21 levels after resection of the primary tumor, showed that FGF21 remained highly expressed in 50% of ccRCC patients during early post-surgical follow-up (data not shown). This evidence concerns the gene FGF21 and nonpapillary renal cell carcinoma.